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The recent work of Rier et al. (1) showed
that adult female rhesus monkeys exposed
daily for 4 years to 5 and 25 ppt of2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) in
their food developed endometriosis during
a 10-year follow-up period. The incidence
and severity of endometriosis was dose
related. These findings are extremely
important because endometriosis is a sig-
nificant cause ofdebilitating pain and infer-
tility in women. We sought to determine
whether the levels oftotal TCDD exposure
ofthe monkeys are within the range ofthat
observed in human populations. As an
example, we examined the TCDD levels
for a population acutely exposed, via inges-
tion, inhalation, or dermal contact, after a
chemical plant explosion in Seveso, Italy,
in 1976. A simple toxicokinetic analysis
aimed at comparing monkey and human
total exposure shows the potential for an
increased risk of endometriosis for the
Seveso population.
Our toxicokinetic analysis takes into
account species and exposure differences in
dose and timing between humans and
monkeys through modeling and use of
species-specific parameters. The results are
independent ofthe route ofabsorption dif-
ferences because they are based on mea-
sured internal (blood or fat) concentration
data. The exposures for humans in Seveso
and monkeys in the Rier et al. study are
comparable because for both the exposure
was predominantly to TCDD with no sig-
nificant exposure to the other polychlori-
nated dibenzo-p-dioxin and polychlorinat-
ed dibenzofuran congeners (2) Total expo-
sure is estimated though the area under
time-concentration curve (AUC), which is
a standard way to estimate long-term inter-
nal exposure to bioaccumulating chemi-
cals. It is likely that a concentration of 100
ppt dioxin in blood, maintained for 2
years, is more toxic than the same concen-
tration experienced for 1 week. The prod-
uct of concentration and time is then a
simple but suitable measure of exposure,
more closely related to the effect than con-
centration. The AUC goes further by tak-
ing into account the fact that concentra-
tions may change with time.
Bowman et al. (3) report that in a
group of four of the rhesus monkeys used
in Rier et al.'s study, the measured TCDD
half-life ranged from 180 days to 788 days.
After 4 years ofexposure to 25 ppt TCDD
in the diet, the whole-weight adipose tissue
concentrations were in the range of
245-812 ppt. We assume that one-com-
partment kinetics apply for TCDD in
monkeys and humans. Such an assump-
tion is reasonable because TCDD is essen-
tially stored in fat. Over time, the slow
release from the fat compartment becomes
the limiting factor ofelimination from the
body, and TCDD blood concentration at
each time is proportional to the fat con-
centration. Standard results on multiple-
Table 1. Toxicokinetic parameters and estimated
area under the adipose tissue concentration
curve (over 14years) for rhesus monkeys exposed
dailyfor 4years to 25 pptTCDD in diet
Monkey
IDa
PP91
PP100
PP104
PP1 0
TCDD
half-lifea
(days)
180
788
540
491
Adipose tissue
conc.ab
(ppt)
245
665
812
735
Estimated
AUcC
(ppt x day)
358,000
1,312,000
1,395,000
1,227,000
aData from Bowman et al. (3).
bWhole-weight adipose tissue concentration at
the end of exposure.
CArea under curve (AUC) for a 14-year period (4-
year exposure to 25 ppt and 10-year follow-up),
assuming one-compartment kinetics.
dosing kinetics (4) give theAUC for adipose
tissue concentration for these monkeys
over a 14-year follow-up period (Table 1).
These AUCs range from about 350,000
ppt x day to 1,400,000 ppt x day. The
kinetic analysis also indicates that, after 4
years of exposure, concentration levels
reached 72-99% of their steady-state val-
ues, depending on the animal.
Mocarelli et al. (5) provide, for 19
Seveso subjects (males and females), the
concentration of TCDD in blood (lipid
adjusted) at time of last known exposure
(Table 2). Whole-weight adipose tissue
concentration can be derived from blood
concentration using the data of Patterson
et al. (6) in occupationally exposed indi-
viduals. Whole-weight adipose tissue con-
centrations are obtained by dividing lipid-
adjusted concentrations by a factor of 1.5;
lipid-adjusted concentrations in adipose
and serum are practically the same (6). For
one woman (subject Seveso W), whole-
weight adipose tissue concentration was
directly measured (6) and does not need
to be estimated. Given an estimated half-
life for TCDD of7 years in humans, taken
to be independent ofsex and age (5,7), it
is easy to compute the AUC for whole-
weight adipose tissue concentration for
1976-1993 (Table 2). The blood AUCs
are expected to be proportional to those for
adipose tissue and in the same proportion
for both monkeys and humans. The portion
of AUC from first to last contact time at
Seveso was neglected because it is small
compared to the rest ofthe area (the expo-
sure period was only 1 or 2 months).
These AUCs range from approximately
1,660,000 ppt x day to 112,000,000
ppt/day (on average 24,000,000 ppt x
day). The AUCs exceed in all cases the val-
ues for monkeys exposed to 25 ppt and
should also exceed those for the monkeys
exposed to 5 ppt. For any subject, the
AUC for 1976-1993 represents 85% of
the AUC for 1976-2011, the latter being a
measure of the total exposure potentially
incurred by the Seveso subjects (assuming
that on average they had half a lifetime,
i.e., 35 years, left to live at the time of
exposure). Therefore, the subjects have
already received most ofthe total integrat-
ed exposure expected.
According to this analysis, it is likely
that the total exposure to TCDD for some
of the 1976 Seveso residents is much
greater than that ofthe monkeys exhibiting
endometriosis. Because the monkeys
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Table 2. Lipid-adjusted blood concentrations, estimated whole-weight adipose tissue concentrations,
and estimated areas underthe concentration curve for Seveso residents
Whole-weight
Lipid-adjusted adipose tissue Estimated AUCC
Human Da blood concentrations(ppt) concentration (ppt) (pptx day)
Seveso 01 56,000 37,333 112,052,000
Seveso 02 27,800 18,533 55,626,000
Seveso 03 26,400 17,600 52,825,000
Seveso 04 26,000 17,333 52,024,000
Seveso 05 15,900 10,600 31,815,000
Seveso 06 12,100 8,067 24,211,000
Seveso 07 17,300 11,533 34,616,000
Seveso 08 7,420 4,947 14,847,000
Seveso 09 1,690 1,127 3,382,000
Seveso 10 828 552 1,657,000
Seveso 11 10,400 6,933 20,810,000
Seveso 12 9,140 6,093 18,289,000
Seveso 13 6,320 4,213 12,646,000
Seveso 14 5,560 3,707 11,125,000
Seveso 15 4,540 3,027 9,084,000
Seveso 16 3,730 2,487 7,463,000
Seveso 17 3,050 2,033 6,103,000
Seveso 18 2,650 1,767 5,302,000
Seveso 19 1,770 1,180 3,542,000
Seveso W NAd 1,840 5,523,000
8Concentration inthe lipid fraction ofthe adiposetissue; data from Mocarelli etal.(5) and Patterson etal. (6).
bObtained by dividing lipid-adjusted blood concentrations by a factor of 1.5(seetext).
CArea under curve (AUC) for whole-weight adipose tissue concentration was estimated assuming one-
compartment kinetics and a half-life of7 years forTCDD in humans.
dNot available;whole-weight adipose tissue concentration was directly measured forthis subject(6).
exposed to 5 ppt in diet also had an
increased risk of endometriosis, popula-
tions exposed to lower levels than those in
Seveso may also be at increased risk if
humans are at least as sensitive to the expo-
sure as monkeys. To date, no epidemiolog-
ic study has investigated the gynecologic
effects of TCDD; given its exposure, the
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